VFM
FLGT icon

Vision Financial Markets’s Fulgent Genetics FLGT Stock Holding History

Vision Financial Markets’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$1.59K – 419
2026
Q1 		$1.59K Hold
100
– – ﹤0.01% 344
2025
Q4 		$2.63K Hold
100
– – ﹤0.01% 304
2025
Q3 		$2.26K Hold
100
– – ﹤0.01% 339
2025
Q2 		$1.99K Hold
100
– – ﹤0.01% 336
2025
Q1 		$1.69K Buy
+100
New +$1.7K ﹤0.01% 326

Other funds holding FLGT

PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
TG
TCW Group Los Angeles, California $14.9B AUM 46.29% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
CMF
Counterpoint Mutual Funds San Diego, California $1.01B AUM 37.65% 1-Year Est. Return
MAM
Marquette Asset Management Minneapolis, Minnesota $779M AUM 23.4% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Vision Financial Markets's FLGT Position: Q2 2026 in Review

Vision Financial Markets sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 100 shares — an estimated $1.59K sold.

Vision Financial Markets first reported a position in FLGT in Q1 2025 and held it in 5 quarters. The position peaked at $2.63K in Q4 2025. 40 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • Vision Financial Markets reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • Vision Financial Markets sold 100 Fulgent Genetics shares in Q2 2026, an estimated $1.59K.
  • Vision Financial Markets first reported a position in Fulgent Genetics in Q1 2025 and held it in 5 quarters.
  • Vision Financial Markets's Fulgent Genetics position peaked at $2.63K in Q4 2025.
  • 40 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.